Intellipharmaceutics Balance Sheet - Quarterly (NASDAQ:IPCI)

Add to My Stocks
$2.51 $0.22 (8.06%) IPCI stock closing price Sep 18, 2018 (Closing)

The financial analysis of a company like Intellipharmaceutics involves checking the three financial statements of the company in detail, of which the balance sheet is one. Financial strength can be guaged by performing Intellipharmaceutics stock analysis and by analyzing the balance sheet. Quarterly results are typically accompanied with the company releasing financial statements. Intellipharmaceutics balance sheet as at the end of 2018 Q2 indicates an asset turnover ratio of 0.39 and debt to equity ratio of -. Also check Intellipharmaceutics revenue and Intellipharmaceutics operating cash flow for the same period.

View and download Intellipharmaceutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Dec - Nov2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.18M1.08M--1.06M1.18M1.08M---
Total Current Assets
Property Plant & Equipment8.03M7.97M7.94M7.86M7.56M6.76M6.04M---
Accumulated Depreciation4.97M4.82M4.67M4.49M4.35M4.24M4.15M---
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable2.93M2.86M2.06M2.53M1.95M1.01M-1.53M3.47M2.44M
Current Portion Long-Term Debt1.32M1.3M1.29M1.31M1.26M1.32M1.49M1.49M1.48M1.48M
Current Portion Capital Leases----------
Accrued Expenses-1.35M---1.7M1.42M---
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income2.21M2.28M2.36M2.43M2.51M2.58M2.66M---
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net38.7M35.29M35.29M32.46M31.53M30.73M29.83M27.62M23.14M22.11M
Capital Surplus37.87M36.72M36.68M35.82M35.79M34.86M34.01M32.94M31.59M31.53M
Retained Earnings-77.88M-75.02M-71.87M-69.36M-66.81M-65M-63.01M-59.1M-56.99M-54.99M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity-1.03M-2.72M--0.79M--1.11M1.75M-1.96M-1.05M
Total Liabilities & Shareholders Equity6.67M5.39M7.39M6.65M7.77M7.95M7.97M5.36M3.81M3.81M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our AMNEAL PHARMACT financial analysis

Looking at Intellipharmaceutics historical stock prices and the current Intellipharmaceutics stock price can tell you how the stock price has moved, whereas the Intellipharmaceutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Intellipharmaceutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Intellipharmaceutics had total assets of $6.67M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Intellipharmaceutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for IPCI stock stand at $7.7M.

Intellipharmaceutics Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover